SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Plethico Pharmaceuticals Board approves Bonus share

03 Jun 2013 Evaluate

Plethico Pharmaceuticals has informed that the Board of Directors of the Company at its meeting held on June 01, 2013, has decided in-principle to issue bonus shares to the shareholders other than promoters /promoter group shareholders in the ratio of 1 Share for every 5 Shares held by them subject to necessary approval of SEBI for waiver of certain condition stipulated under SEBI ICDR Regulations and/or extension of time to comply with the Minimum Public Shareholding (MPS) requirements. The Issue of Bonus share will be implemented only on receipt of approval from SEBI.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1941.00
Dr. Reddys Labs. 1152.60
Cipla 1410.90
Lupin 2369.45
Zydus Lifesciences 1108.90
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: